Literature DB >> 1763674

Consensus development conference statement.

.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1763674     DOI： 10.1002/jbmr.5650061406

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  16 in total

Review 1.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

2.  The changing pattern of diagnosing primary hyperparathyroidism in young patients.

Authors:  Irene Lou; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein
Journal:  Am J Surg       Date:  2016-06-14       Impact factor: 2.565

Review 3.  Normocalcemic primary hyperparathyroidism.

Authors:  John P Bilezikian; Shonni J Silverberg
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-03

4.  Increased prevalence of primary hyperparathyroidism in treated breast cancer.

Authors:  P Fierabracci; A Pinchera; P Miccoli; P F Conte; E Vignali; M Zaccagnini; C Marcocci; C Giani
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

5.  Tuberculous granulomatous inflammation associated with adenoma of parathyroid gland manifesting as primary hyperparathyroidism.

Authors:  D K Kar; G Agarwal; B Mehta; J Agarwal; R K Gupta; T N Dhole; S K Mishra
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.

Authors:  T Diamond; A T Ng; S Levy; C Magarey; R Smart
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test.

Authors:  P Hagag; I Revet-Zak; N Hod; T Horne; M J Rapoport; M Weiss
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 8.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; E Vignali; S Borsari; A Picone; L Cianferotti; E Ambrogini; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

Review 10.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.